U.S., July 22 -- ClinicalTrials.gov registry received information related to the study (NCT07715864) titled 'Naturally Produced Cannabinoids for Neuroprotection From Concussion' on June 23.
Brief Summary: The goal of this double-blind, placebo-controlled, cross over study is to learn about the neuroprotective properties of a broad-spectrum cannabinoid formulation in normal healthy adults engaged in elite contact sport competition.
The main question it aims to answer :
* Is the broad-spectrum cannabinoid formulation neuroprotective for athletes participating in competitive contact sports? Can this formulation facilitate recovery in those who suffer from concussion by reducing inflammation and/or reduce the number of concussions sustained ...